Catherine did an MEng in Engineering and Computer Science at Oxford (1999-2003) followed by an MPhil in Computer Speech Text and Internet Technology at Cambridge and a PhD in Engineering at Cambridge. In 2008, she went on to become a Research Engineer at Toshiba Research Ltd, then in 2012 a Research Associate at the Engineering Department in Cambridge, and finally joined Amazon in 2014 as a speech scientist. She now leads a team of scientists in Cambridge working across automatic speech recognition and natural language understanding for Amazon Alexa.
Dr Camille Terfve, Trainee Patent Attorney
Camille has a BSc in Engineering from Université Libre de Bruxelles, where she graduated in 2007. She went on to do an MSc in Chemical & Bio-engineering at the same university, and in 2009 was awarded a full scholarship from the Wiener-Anspach Foundation to do an MPhil in Computational Biology in Cambridge, where in 2010 she started her PhD at the Graduate School of Life Sciences. Since October 2014 she has been training to be a Patent Attorney at Keltie, where thanks to her broad scientific background she has been given the opportunity to acquire experience in a wide variety of fields including biotechnology, control systems, automotive, mechanical devices, chemicals and petrochemicals, software (including financial), telecommunications, synthetic biology and bioinformatics.
Dr Andrew Thomas, Research Team Leader at Astrazeneca
Andrew received his BSc in Chemistry from the University of Kent at Canterbury (1981-83) before moving to Cambridge to carry out his doctoral research at the Department of Chemistry (1983-86). He then obtained a SERC-NATO post-doctoral fellowship and carried out research at the University of Wisconsin – Madison and Stanford University from 1986 until 1988
He returned to the UK to work for ICI Pharmaceuticals at Alderley Park, Cheshire in 1988 as a medicinal chemistry team leader. Working at Alderley through a demerger and a merger, he moved to the Cambridge area as part of the AstraZeneca relocation in early 2015. For the vast majority of his career in the pharmaceutical industry, he worked in oncology research. He was a key member of the project teams that discovered the registered drugs gefitinib (Iressa) and vandetanib (Caprelsa), the candidate drugs AZD5438 and AZD4547 which progressed to phase II testing, as well as helping to initiate and progress several other key projects
In addition to internal project work, Andrew is part of the team responsible for assessment and due diligence of in-licensing opportunities; he leads the scientific ladder in AZ oncology chemistry and sits on leadership teams in chemistry and oncology iScience. He is an author on more than 20 peer-reviewed papers and inventor on more than 40 patent applications. He is also a member of the Imperial College Institute of Chemical Biology Research Board and has been a member of Organic Division Committee of the Royal Society of Chemistry.
Dr Hilary Custance Green, writer
Hilary has had an unusual career,. She was a sculptor for 20 years, did brain research at the MRC for 16 years, studying the attention systems of the brain, and is now a writer. She was 50 when she proceeded to her PhD at Darwin and is 69 now. As a child she lived in England, Gibraltar and Germany and went to school in Belgium. She took a degree in Art History and then another in Fine Art Sculpture, after which she worked as a sculptor for many years. She also took an Open University degree in Psychology, followed by her PhD at Cambridge.
Hilary’s first novel, A Small Rain, was written alongside her PhD. After two more novels (“Unseen Unsung” and “Border Line”), in June last year her non-fiction research into the experiences of her father, who was captured by the Japanese during the second world war, resulted in her book “Surviving the Death Railway: a POW’s Memoirs and Letters from Home”.
Dr Jennifer Schooling, Director of the Cambridge Centre for Smart Infrastructure and Construction
Jennifer did a BA in Materials Science at Cambridge, where she graduated in 1993, followed by a PhD in the same department, which she finished in 1997. From 1998 until 2005, she worked as New Product Introduction Manager at Edwards Vacuum (then BOC Edwards) for turbomolecular pumps for the semiconductor and scientific instrument industries. She then worked for a year as a volunteer maths teacher at Our Lady and the Visitacion school, San Francisco, USA, which was followed by 7 years as Research Business Manager for Ove Arup and Partners ltd, the global engineering consultancy.
Since 2013, Jennifer has been the Director of the Cambridge Centre for Smart Infrastructure and Construction at the University of Cambridge.
Dr Michael Rice, Affiliated Lecturer, Institute of Criminology
Michael began his undergraduate career at Oxford as a lawyer but ended it as a mediaeval linguist. He then worked for the Survey Research Centre at the London School of Economics. Subsequently, with funding from the Joseph Rowntree Trust, he directed a successful planning law reform campaign, and for a time he was Will Hutton's gardener. In posts funded by the Home Office, he worked on health and education as a Parliamentary liaison officer at Westminster.
Before his arrival in Cambridge as a mature graduate student, Michael was active in local politics in north London, taking particular interest in housing and the built environment. For his doctoral study of prisoners' reading abilities he spent over two hundred days-but no nights-behind bars. On completion of this research, he worked for Nacro's Crime and Social Policy section, beginning with an evaluation of ten community safety schemes in London. He now teaches courses on crime and deviance, sentencing policy, elementary statistical analysis and survey research methods to graduate and undergraduate students in the Faculties of Law and Human, Social, and Political Science (HSPS).
Dr Alex Gutteridge, Director in GSK’s Statistics and Computational Biology group
Alex graduated from Darwin with a PhD in Bioinformatics in 2005 (after completing his undergraduate studies in Biochemistry and working for a short time at a biotech
startup). Following his PhD he moved to the University of Kyoto in Japan as a Japanese government (JSPS) funded research fellow.
After two years in Japan he moved back to the University of Cambridge for a second post-doctoral appointment, this time in the Department of Biochemistry.
In 2010, he decided to leave academia and took up a position as a Principal Scientist in R&D within the large pharma company Pfizer. During his 6 years at Pfizer he worked on applying computational biology to most aspects of drug discovery and development with a particular focus on regenerative medicine, neuroscience and genetics. Since 2016, Alex has been at GSK working on Neuroscience and the application of genomics for drug development.
Dr Antony Sou, IC Design Manager at PragmatIC
Antony has a BSc in Electronics from UMIST and did his Cambridge PhD on the principles of OFET modelling and circuit design under the supervision of Professor Henning Sirringhaus. From 1995 to 2009, he worked for a number of small and large technology companies including ICL and Fujitsu, before working for five years as a postdoctoral researcher in the Optoelectronics Group of the Cavendish Laboratory where he researched circuit design with metal-oxide and organic transistors, cooperating closely with industrial partners on flexible applications.
Antony is currently IC Design Manager at PragmatIC, engaged on the research and design of large-scale mixed-signal integrated chips on flexible transparent plastics
Sou is an expert integrated circuit designer with extensive experience in metal-oxide, organic and silicon semiconductor technologies having worked for several major global technology companies in multiple worldwide locations.
He is the author of the book, “Practical Guide To Organic Field Effect Transistor (OFET) Circuit Design”, has patents relating to high speed serial communications links such as USB and PCI-Express, and has also published in leading journals and presented at conferences.